Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-19

Clinical Trial Update: Assessment of the Anti-inflammatory Effect of Heparin Infusion Versus Subcutaneous Injection in Septic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing anti-inflammatory effects of heparin infusion versus subcutaneous injection in septic, critically ill patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Heparin (unfractionated heparin)

Snippet

Sponsor: Damanhour University | Conditions: Sepsis, Critical Illness | Phase 2 | Status: COMPLETED